Massachusetts Financial Services Co. MA Has $105.10 Million Stock Position in Teleflex Incorporated (NYSE:TFX)

Massachusetts Financial Services Co. MA increased its stake in Teleflex Incorporated (NYSE:TFX) by 38.1% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 590,529 shares of the medical technology company’s stock after purchasing an additional 162,950 shares during the quarter. Massachusetts Financial Services Co. MA owned approximately 1.27% of Teleflex worth $105,102,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of the stock. Vontobel Holding Ltd. raised its holdings in shares of Teleflex by 21.9% during the fourth quarter. Vontobel Holding Ltd. now owns 1,393 shares of the medical technology company’s stock valued at $248,000 after acquiring an additional 250 shares during the period. JPMorgan Chase & Co. grew its position in Teleflex by 14.3% during the 3rd quarter. JPMorgan Chase & Co. now owns 155,158 shares of the medical technology company’s stock worth $38,374,000 after purchasing an additional 19,466 shares in the last quarter. Sumitomo Mitsui Trust Group Inc. raised its stake in Teleflex by 5.2% during the 4th quarter. Sumitomo Mitsui Trust Group Inc. now owns 108,231 shares of the medical technology company’s stock valued at $19,263,000 after purchasing an additional 5,322 shares during the period. Lecap Asset Management Ltd. purchased a new stake in shares of Teleflex in the fourth quarter valued at $729,000. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in shares of Teleflex by 35.1% in the fourth quarter. Mirae Asset Global Investments Co. Ltd. now owns 5,875 shares of the medical technology company’s stock worth $1,053,000 after buying an additional 1,527 shares during the period. Institutional investors and hedge funds own 95.62% of the company’s stock.

Teleflex Stock Performance

Shares of TFX opened at $131.93 on Friday. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex Incorporated has a 12 month low of $128.55 and a 12 month high of $249.91. The company’s fifty day moving average is $154.86 and its 200-day moving average is $187.03. The firm has a market cap of $6.12 billion, a price-to-earnings ratio of 26.23, a price-to-earnings-growth ratio of 1.73 and a beta of 1.21.

Teleflex (NYSE:TFX) last posted its earnings results on Thursday, February 27th. The medical technology company reported $3.89 earnings per share for the quarter, beating the consensus estimate of $3.86 by $0.03. The company had revenue of $795.40 million for the quarter, compared to analyst estimates of $813.24 million. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. Equities analysts expect that Teleflex Incorporated will post 13.98 EPS for the current fiscal year.

Teleflex Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Monday, March 17th. Shareholders of record on Friday, March 7th were issued a dividend of $0.34 per share. The ex-dividend date was Friday, March 7th. This represents a $1.36 annualized dividend and a yield of 1.03%. Teleflex’s dividend payout ratio (DPR) is presently 95.77%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on TFX. Royal Bank of Canada lowered Teleflex from an “outperform” rating to a “sector perform” rating and dropped their price target for the company from $220.00 to $155.00 in a research report on Friday, February 28th. Citizens Jmp downgraded Teleflex from an “outperform” rating to a “market perform” rating in a report on Thursday, February 27th. StockNews.com cut shares of Teleflex from a “buy” rating to a “hold” rating in a report on Friday, February 28th. Needham & Company LLC reiterated a “hold” rating on shares of Teleflex in a research note on Wednesday, March 12th. Finally, Raymond James lowered shares of Teleflex from an “outperform” rating to a “market perform” rating in a research note on Friday, February 28th. One equities research analyst has rated the stock with a sell rating, nine have assigned a hold rating and two have given a buy rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $182.63.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.